Tuesday, June 1, 2021

Eli Lilly gets DCGI emergency use approval for COVID-19 antibody cocktail drug

Eli Lilly gets DCGI emergency use approval for COVID-19 antibody cocktail drug Lilly said it is engaged in active dialogue with the Indian government and regulatory authorities to donate bamlanivimab and etesevimab in order to speed up access and provide treatment options for patients with COVID-19.

from Moneycontrol Business News https://ift.tt/3p6Q9cZ
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Nepal protests: A Nepali citizen shares the real reason why Gen Z is up in arms, and it’s not just about social media ban

Nepal Protests News: Protests in Nepal, initially sparked by a social media ban affecting platforms like Facebook and WhatsApp, have escalat...